From: Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target
ML model
Accuracy
Sensitivity
Specificity
MCC
Precision
Recall
KNN
96%
0.87
0.98
0.86
0.89
SVM
94%
0.85
0.96
0.81
RF
98%
0.95
0.99
0.97
0.93
GNB
89%
0.90
0.68
0.80